Search Results

595 Results for "modernatx".

Sort By

Press Releases

Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada

September 9, 2024
·
4 min read
Press Releases

Moderna to Host Investor Event - R&D Day and Business Updates

August 22, 2024
·
1 min read
Business

Harbour BioMed Enters into a License and Collaboration Agreement with Moderna

Harbour BioMed (the “Company”, HKEX: 02142) today announced that Nona Biosciences, a subsidiary wholly owned by the Company, had entered into a license and collaboration agreement with ModernaTX, Inc. (NASDAQ: MRNA), a global biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines.

November 10, 2022
·
3 min read
Press Releases

Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

September 3, 2024
·
2 min read
Business

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination

August 29, 2024
·
3 min read
Press Releases

Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1

August 23, 2024
·
4 min read
Press Releases

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

September 5, 2024
·
4 min read
Press Releases

Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1

September 3, 2024
·
4 min read
FDA

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2

August 22, 2024
·
6 min read
Press Releases

Moderna and Coursera Launch Free Course on mRNA Technology

August 14, 2024
·
4 min read